Abivax
6 known investors
Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.
BiotechHealthtechMedical Devices
Investors Β· 6
Competitors Β· 6
by search overlapDynavax NASDAQ: DVAX www.dynavax.com40 shared keywordsDynavax is a biopharmaceutical company that develops and commercializes vaccines to protect against infectious diseases, including HEPLISAV-B, a two-dose adult hepatitis B vaccine, and its CpG 1018 adjuvant used in multiple vaccines. The company also advances a pipeline of novel vaccine clinical candidates.
Robinhood37 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha37 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Vaccinex35 shared keywordsVaccinex is a clinical-stage biotechnology company developing pepinemab (VX15/2503), a humanized monoclonal antibody that blocks SEMA4D signaling, in trials for neurological disorders such as Huntington's and Alzheimer's disease and for solid tumors including breast cancer, melanoma, non-small cell lung cancer and head and neck cancer. It also offers a fusion protein and ActivMab antibody discovery technology for incorporating membrane proteins such as GPCRs and ion channels into poxviruses for antibody selection.
Stocktwits34 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Imvax34 shared keywordsImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies competing with Abivax for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Abivax do?
- Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.
- Who are Abivax's investors?
- Abivax's investors include Andera Partners, Claret Capital Partners, Medicxi, Samsara BioCapital, Sofinnova Partners, Truffle Capital.